The reduction in price target by Cantor Fitzgerald reflects a negative outlook on Humana's stock price in the short term. A lower price target, especially when maintained with a Neutral rating, suggests that the analyst sees limited upside potential or increased risk factors that could pressure the stock. This could lead to a negative sentiment among investors and potentially a decrease in stock price in the short term.